Analysis of three different glioma-related datasets in the GEO database, including dozens of normal brain samples and hundreds of glioma samples, revealed that the expression level of CKAP2L in glioma tissues was significantly higher (P < 0.05) than that in normal brain tissue, as shown in Figures 1(b)–1(d). This evidence concerns the gene CKAP2L and central nervous system cancer.